Search Type: drug or dietary supplement name Search Term: deferiprone (FERRIPROX)
Additional Information from Public Citizen
Search results below include Additional Information from Public Citizen where your selected drug is a primary subject of discussion
Letter to FDA Opposing Approval of Deferiprone (HRG Publication #1973)
[hide all summaries]
We strongly oppose FDA approval of ApoPharma’s NDA for deferiprone for treatment of patients with transfusional iron overload when current chelation therapy is inadequate because the data presented by the sponsor in support of the NDA were grossly insufficient and fail to demonstrate that deferiprone is safe and effective in the intended patient population.